1887

Abstract

The selection and characterization of a set of mouse mAbs against high-risk human papillomavirus (HPV) E7 oncoprotein and the development of protocols for immunocytochemistry (ICC) are described here. A large number of antibodies raised towards HPV16 and 18 E7 were tested for high-risk specificity by ELISA using a panel of HPV E7 proteins. Antibodies detecting low-risk E7 were discarded, resulting in 38 high-risk HPV E7-specific antibodies. The corresponding epitopes were mapped using overlapping HPV E7 fragments displayed on phage particles. Functionality in ICC against formalin-fixed cervical cancer cell lines was demonstrated for ten mAbs; their high-risk specificity was confirmed by Western blot analysis and ICC on transiently transformed cells expressing high- or low-risk HPV E7. These mAbs were specific for one or several of the high-risk strains HPV16, 18, 31, 35 and 45. Specific E7 staining of liquid-based cytology (LBC) samples was demonstrated for seven mAbs and optimized protocols were established. The E716-41 and E718-79 mAbs demonstrated particularly strong and specific staining of cells stored in LBC fluid for at least 6 months. It is proposed that the high-risk HPV E7 staining protocols established in this study may have the potential to be included in a complementary test for the detection and identification of malignantly transformed cells, in for example atypical squamous cells of undetermined significance samples.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.034884-0
2012-02-01
2020-08-11
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/2/356.html?itemId=/content/journal/jgv/10.1099/vir.0.034884-0&mimeType=html&fmt=ahah

References

  1. Arbyn M., Bergeron C., Klinkhamer P., Martin-Hirsch P., Siebers A. G., Bulten J.. 2008; Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol111:167–177 [CrossRef][PubMed]
    [Google Scholar]
  2. Bernard H. U., Burk R. D., Chen Z., van Doorslaer K., Hausen H., de Villiers E. M.. 2010; Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology401:70–79 [CrossRef][PubMed]
    [Google Scholar]
  3. Bonnycastle L. L. C., Menendez A., Scott J. K.. 2001; General Phage Methods. In Phage Display: a Laboratory Manual pp.15.1–15.30 Edited by Barbas C. F., Burton D. R., Scott J. K., Silverman G. J.. Cold Spring Harbour, New York: Cold Spring Harbour Laboratory;
    [Google Scholar]
  4. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C.. other authors 2009; A review of human carcinogens–Part B: biological agents. Lancet Oncol10:321–322 [CrossRef][PubMed]
    [Google Scholar]
  5. Castle P. E.. 2008; Invited commentary: is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening?. Am J Epidemiol168:138–144, discussion 145–148 [CrossRef][PubMed]
    [Google Scholar]
  6. de Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., Bosch F. X.. 2007; Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis7:453–459 [CrossRef][PubMed]
    [Google Scholar]
  7. de Sanjosé S., Quint W. G., Alemany L., Geraets D. T., Klaustermeier J. E., Lloveras B., Tous S., Felix A., Bravo L. E.. other authors 2010; Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol11:1048–1056 [CrossRef][PubMed]
    [Google Scholar]
  8. de St Groth S. F., Scheidegger D.. 1980; Production of monoclonal antibodies: strategy and tactics. J Immunol Methods35:1–21 [CrossRef][PubMed]
    [Google Scholar]
  9. Doorbar J.. 2006; Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond)110:525–541 [CrossRef][PubMed]
    [Google Scholar]
  10. Jeon J. H., Shin D. M., Cho S. Y., Song K. Y., Park N. H., Kang H. S., Kim Y. D., Kim I. G.. 2007; Immunocytochemical detection of HPV16 E7 in cervical smear. Exp Mol Med39:621–628[PubMed][CrossRef]
    [Google Scholar]
  11. Kitchener H. C., Castle P. E., Cox J. T.. 2006; Chapter 7: achievements and limitations of cervical cytology screening. Vaccine24:Suppl. 3S63–S70 [CrossRef][PubMed]
    [Google Scholar]
  12. Koutsky L.. 1997; Epidemiology of genital human papillomavirus infection. Am J Med102:Suppl. 13–8 [CrossRef][PubMed]
    [Google Scholar]
  13. Lidqvist M., Nilsson O., Holmgren J., Hall C., Fermér C.. 2008; Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies. J Immunol Methods337:88–96 [CrossRef][PubMed]
    [Google Scholar]
  14. Schiffman M., Castle P. E.. 2003; Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med127:930–934[PubMed]
    [Google Scholar]
  15. Schiffman M., Wentzensen N., Wacholder S., Kinney W., Gage J. C., Castle P. E.. 2011; Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst103:368–383 [CrossRef][PubMed]
    [Google Scholar]
  16. van der Loos C. M.. 2007; A focus on fixation. Biotech Histochem82:141–154 [CrossRef][PubMed]
    [Google Scholar]
  17. von Knebel Doeberitz M.. 2002; New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer38:2229–2242 [CrossRef][PubMed]
    [Google Scholar]
  18. Walboomers J. M. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J. F., Peto J., Meijer C. J. L. M., Muñoz N.. 1999; Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol189:12–19 [CrossRef][PubMed]
    [Google Scholar]
  19. WHO/ICO Information Centre on HPV and Cervical Cancer 2007; HPV and cervical cancer in the 2007 report. Vaccine25:Suppl. 3C1–C230[PubMed][CrossRef]
    [Google Scholar]
  20. zur Hausen H.. 1996; Papillomavirus infections–a major cause of human cancers. Biochim Biophys Acta1288:F55–F78[PubMed]
    [Google Scholar]
  21. zur Hausen H.. 2002; Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer2:342–350 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.034884-0
Loading
/content/journal/jgv/10.1099/vir.0.034884-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error